182 related articles for article (PubMed ID: 10980996)
41. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
[TBL] [Abstract][Full Text] [Related]
42. Eradication of Helicobacter pylori infection after ranitidine bismuth citrate, metronidazole and tetracycline for 7 or 10 days.
Knigge K; Kelly C; Peterson WL; Fennerty MB
Aliment Pharmacol Ther; 1999 Mar; 13(3):323-6. PubMed ID: 10102965
[TBL] [Abstract][Full Text] [Related]
43. Helicobacter pylori eradication therapy.
Suzuki H; Nishizawa T; Hibi T
Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
[TBL] [Abstract][Full Text] [Related]
44. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Van der Wouden EJ; Thijs JC; Zwet AA; Kooy A; Kleibeuker JH
Aliment Pharmacol Ther; 1999 Mar; 13(3):297-302. PubMed ID: 10102961
[TBL] [Abstract][Full Text] [Related]
45. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
46. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Gisbert JP; Carpio D; Marcos S; Gisbert JL; García Grávalos R; Pajares JM
Eur J Gastroenterol Hepatol; 2000 May; 12(5):489-95. PubMed ID: 10833090
[TBL] [Abstract][Full Text] [Related]
47. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
[TBL] [Abstract][Full Text] [Related]
48. [History of the treatment of Helicobacter pylori and clinical efficacy].
Yamamoto I; Fukuda Y; Shimoyama T
Nihon Rinsho; 1999 Jan; 57(1):32-42. PubMed ID: 10036933
[TBL] [Abstract][Full Text] [Related]
49. Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy.
Rinaldi V; Zullo A; De Francesco V; Hassan C; Winn S; Stoppino V; Faleo D; Attili AF
Aliment Pharmacol Ther; 1999 Feb; 13(2):163-8. PubMed ID: 10102945
[TBL] [Abstract][Full Text] [Related]
50. A triple therapy regimen after failed Helicobacter pylori treatments.
Zullo A; Hassan C; Campo SM; Lorenzetti R; Febbraro I; De Matthaeis M; Porto D; Morini S
Aliment Pharmacol Ther; 2001 Aug; 15(8):1193-7. PubMed ID: 11472322
[TBL] [Abstract][Full Text] [Related]
51. Current regimens for treatment of Helicobacter pylori infection.
Harris A
Br Med Bull; 1998; 54(1):195-205. PubMed ID: 9604443
[TBL] [Abstract][Full Text] [Related]
52. 14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
Thong-Ngam D; Mahachai V
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S119-25. PubMed ID: 17718277
[TBL] [Abstract][Full Text] [Related]
53. Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.
Pozzato P; Zagari M; Cardelli A; Catalano FA; Giglio A; Lami F; Pilotto A; Scarpulla G; Spadaccini A; Susi D; Tosatto R; Olivieri A; Bazzoli F; Roda E
Aliment Pharmacol Ther; 1998 May; 12(5):447-51. PubMed ID: 9663724
[TBL] [Abstract][Full Text] [Related]
54. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
[TBL] [Abstract][Full Text] [Related]
55. Helicobacter pylori infection--current treatment practice.
Xia HH; Yu Wong BC; Talley NJ; Lam SK
Expert Opin Pharmacother; 2001 Feb; 2(2):253-66. PubMed ID: 11336584
[TBL] [Abstract][Full Text] [Related]
56. Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
Farup PG; Tholfsen J; Wetternus S; Torp R; Høie O; Lange OJ
Scand J Gastroenterol; 2002 Dec; 37(12):1374-9. PubMed ID: 12523585
[TBL] [Abstract][Full Text] [Related]
57. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
[TBL] [Abstract][Full Text] [Related]
58. Helicobacter pylori eradication in peptic dyspepsia.
Lule GN
East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
[No Abstract] [Full Text] [Related]
59. Helicobacter pylori.
Meyer JM; Hopkins RJ
N Engl J Med; 2003 Jan; 348(4):363-5. PubMed ID: 12540657
[No Abstract] [Full Text] [Related]
60. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
de Boer WA; Haeck PW; Otten MH; Mulder CJ
Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
